Translational Development Acquisition Corp. · NASDAQ:TDAC
AQR Capital Management LLC reported a 6.38% stake in Translational Development Acquisition Corp. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
AQR Capital Management LLC reported a 6.38% stake in Translational Development Acquisition Corp., 1,099,989 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 6.38%
- Shares
- 1,099,989
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AQR Capital Management, LLC | 6.38% | 1,099,989 |
| AQR Capital Management Holdings, LLC | 6.38% | 1,099,989 |
| AQR Arbitrage, LLC | 6.38% | 1,099,989 |
Source
Related
- Translational Development Acquisition Corp.
- AQR Capital Management LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G · AQR Capital Management LLC · Feb 14, 2025
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G · Meteora Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 16, 2026
- Schedule 13G · Linden Advisors LP · Jun 2, 2026